Last reviewed · How we verify

NCT04052100

Multimodal Prehabilitation in Thoracic Surgery

Status unknown NA Last updated 11 December 2019
What this trial tests

NA trial testing Usual care in Lung Cancer in 158 participants. Status unknown.

Timeline
1 October 2019
Primary endpoint
31 May 2021
30 June 2021

Quick facts

Lead sponsorHospital Clinic of Barcelona
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment158
Start date1 October 2019
Primary completion31 May 2021
Estimated completion30 June 2021
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Hospital Clinic of Barcelona

Who can join

Eligibility, any sex, with Lung Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This trial aims to assess the impact of a multimodal prehabilitation program in high-risk patients undergoing lung resection surgery.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Cost-effectiveness of a technology-supported multimodal prehabilitation program in moderate-to-high risk patients undergoing lung cancer resection: randomized controlled trial protocol.
    Barberan-Garcia A, Navarro-Ripoll R, Sánchez-Lorente D, Moisés-Lafuente J, et al · · 2020 · cited 17× · PMID 32164687 · DOI 10.1186/s12913-020-05078-9

Verify or expand the search:

Other trials of Usual care

Trials testing the same drug.

Other recruiting trials for Lung Cancer

Currently open trials in the same condition.

Other Hospital Clinic of Barcelona trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04052100.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing